Christopher Nishan Garabedian 4
4 · AVI BIOPHARMA INC · Filed Jan 3, 2011
Insider Transaction Report
Form 4
Christopher Nishan Garabedian
Director
Transactions
- Award
Stock Option (right to buy)
2011-01-02+1,900,000→ 1,900,000 totalExercise: $2.12Exp: 2021-01-02→ Common Stock (1,900,000 underlying)
Footnotes (1)
- [F1]This option is exercisable at the rate of 25% of the shares on January 1, 2012 and 1/48th of the total granted shars on each monthly anniversary thereafter, such that the option will be fully exercisable on January 1, 2015.